Activation of caspases-8 and -10 by FLIP(L) - PubMed (original) (raw)
Activation of caspases-8 and -10 by FLIP(L)
Kelly M Boatright et al. Biochem J. 2004.
Abstract
The first step in caspase activation is transition of the latent zymogen to an active form. For the initiator caspases, this occurs through dimerization of monomeric zymogens at an activating complex. Recent studies have suggested that FLIP(L) [FLICE-like inhibitory protein, long form; FLICE is FADD (Fas-associated death domain protein)-like interleukin-1beta-converting enzyme], previously thought to act solely as an inhibitor of caspase-8 activation, can under certain circumstances function to enhance caspase activation. Using an in vitro induced-proximity assay, we demonstrate that activation of caspases-8 and -10 occurs independently of cleavage of either the caspase or FLIP(L). FLIP(L) activates caspase-8 by forming heterodimeric enzyme molecules with substrate specificity and catalytic activity indistinguishable from those of caspase-8 homodimers. Significantly, the barrier for heterodimer formation is lower than that for homodimer formation, suggesting that FLIP(L) is a more potent activator of caspase-8 than is caspase-8 itself.
Figures
Figure 1. Schematic representation of conserved caspase residues
Conserved residues of the caspase family are shown. As the caspase-1 numbering system is used throughout, this Figure allows translation of conserved residues across the various members of the caspase family. For caspases-8 and -10, the numbering system describing isoform a is used.
Figure 2. FLIPL activates caspase-8 by heterodimerization
(A) Non-cleavable caspase-8 (50 nM) was incubated with either 1 μM FLIPL or 1 μM caspase-8 C285A at the indicated concentrations of sodium citrate at 37 °C, followed 20 min later by the addition of Ac-IETD-AFC. Substrate hydrolysis was followed at 37 °C, and is expressed as relative fluorescence units (RFU)·min−1. (B) Both non-cleavable caspase-8 and FLIPL (each at 7.5 μM) were incubated for 45 min at 37 °C in the presence of 10 mM dithiothreitol and 10 μM Z-VAD-FMK. Following incubation, samples were analysed by size exclusion chromatography on a Superdex 200 column. The broken line indicates samples prepared in the absence of Z-VAD-FMK. (C) Same as (B) with the exclusion of FLIPL; (D) same as (B) with the exclusion of caspase.
Figure 3. Non-cleavable caspase-8 is activated most efficiently by FLIPL and closely approximates endogenous procaspase-8
(A) Caspase-8 cleaved monomer, cleaved dimer or non-cleavable monomer at 75 nM was incubated with an equimolar amount of FLIPL in the presence of 20 mM Tris, pH 7.4, 100 mM NaCl (low-salt buffer) or kosmotrope buffer (containing 0.7 M sodium citrate). After 20 min at 37 °C, Ac-IETD-AFC substrate was added at 100 μM and substrate hydrolysis monitored at 37 °C. Results are expressed as fold increase over caspase alone under the respective buffer conditions. (B, C) Endogenous procaspase-8 from a Jurkat cytosolic extract or non-cleavable caspase-8 prepared in hypotonic buffer at a comparable concentration (15 nM) was immunoprecipitated using polyclonal antisera raised against recombinant caspase-8. (B) Immunoprecipitates were assayed for their ability to hydrolyse Ac-IETD-AFC substrate in the presence or absence of 1 μM FLIPL in either low-salt buffer or kosmotrope buffer as indicated. (C) Western blot of immunoprecipitates using monoclonal anti-caspase-8 antiserum raised against an epitope of the large subunit. (D) Non-cleavable caspase-8, -9 or -10 (500 nM) was added to buffer control, 1 μM of their respective C285A mutant or 1 μM FLIPL in either low-salt buffer or kosmotrope buffer for 20 min at 37 °C before the addition of substrate (Ac-IETD-AFC for caspase-8, Ac-LEHD-AFC for caspase-9, and Ac-DEVD-AFC for caspase-10).
Figure 4. Cleavage of FLIPL is not required for activation of caspase-8, but an ability to form heterodimers is
(A) Non-cleavable caspase-8 (50 nM) was incubated with increasing concentrations of the indicated protein in the presence of 0.7 M sodium citrate for 20 min at 37 °C. Following the activation period, activity was monitored by Ac-IETD-AFC (AFC) hydrolysis. (B) ΔDED caspase-10 (50 nM) was treated as in (A). Following the incubation, activity was monitored by hydrolysis of Ac-DEVD-AFC. Symbols represent FLIP (♦), non-cleavable FLIP D287A (▪), dimer blocking FLIP Q390D (▴), and a catalytic mutant of caspase-8 or -10 (•).
Figure 5. Substrate specificity of the caspase-8 homodimer and the caspase-8/FLIPL heterodimer
Caspase-8 was incubated in 0.7 M sodium citrate in the presence (A) or absence (B) of FLIPL and assayed with a positional scanning substrate library with P1 fixed as aspartic acid. The _y_-axis is the rate of hydrolysis presented as a percentage of the maximal rate observed. The _x_-axis provides the positionally defined
L
-amino acid (single-letter code).
Comment in
- The flip side of FLIP.
Peter ME. Peter ME. Biochem J. 2004 Sep 1;382(Pt 2):e1-3. doi: 10.1042/BJ20041143. Biochem J. 2004. PMID: 15317488 Free PMC article. Review.
Similar articles
- Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW, Shah S. Sylvester PW, et al. Asia Pac J Clin Nutr. 2005;14(4):366-73. Asia Pac J Clin Nutr. 2005. PMID: 16326643 - The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex.
Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW, Briand C, Grütter MG. Micheau O, et al. J Biol Chem. 2002 Nov 22;277(47):45162-71. doi: 10.1074/jbc.M206882200. Epub 2002 Sep 4. J Biol Chem. 2002. PMID: 12215447 - Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.
Sharp DA, Lawrence DA, Ashkenazi A. Sharp DA, et al. J Biol Chem. 2005 May 13;280(19):19401-9. doi: 10.1074/jbc.M413962200. Epub 2005 Mar 10. J Biol Chem. 2005. PMID: 15760909 - The flip side of FLIP.
Peter ME. Peter ME. Biochem J. 2004 Sep 1;382(Pt 2):e1-3. doi: 10.1042/BJ20041143. Biochem J. 2004. PMID: 15317488 Free PMC article. Review. - Targeting the FLICE Inhibitory Protein (FLIP) in cancer therapy.
Wajant H. Wajant H. Mol Interv. 2003 May;3(3):124-7. doi: 10.1124/mi.3.3.124. Mol Interv. 2003. PMID: 14993418 Review.
Cited by
- cFLIP in the molecular regulation of astroglia-driven neuroinflammation in experimental glaucoma.
Yang X, Zeng Q, İnam MG, İnam O, Lin CS, Tezel G. Yang X, et al. J Neuroinflammation. 2024 Jun 1;21(1):145. doi: 10.1186/s12974-024-03141-4. J Neuroinflammation. 2024. PMID: 38824526 Free PMC article. - Deciphering DED assembly mechanisms in FADD-procaspase-8-cFLIP complexes regulating apoptosis.
Yang CY, Lien CI, Tseng YC, Tu YF, Kulczyk AW, Lu YC, Wang YT, Su TW, Hsu LC, Lo YC, Lin SC. Yang CY, et al. Nat Commun. 2024 May 6;15(1):3791. doi: 10.1038/s41467-024-47990-2. Nat Commun. 2024. PMID: 38710704 Free PMC article. - TNF-Related Apoptosis-Inducing Ligand: Non-Apoptotic Signalling.
Guerrache A, Micheau O. Guerrache A, et al. Cells. 2024 Mar 16;13(6):521. doi: 10.3390/cells13060521. Cells. 2024. PMID: 38534365 Free PMC article. Review. - Caspase cleavage of RIPK3 after Asp333 is dispensable for mouse embryogenesis.
Newton K, Wickliffe KE, Maltzman A, Dugger DL, Webster JD, Guo H, Dixit VM. Newton K, et al. Cell Death Differ. 2024 Feb;31(2):254-262. doi: 10.1038/s41418-023-01255-5. Epub 2024 Jan 8. Cell Death Differ. 2024. PMID: 38191748 Free PMC article. - Regulation of apoptosis by ubiquitination in liver cancer.
Li Y, Zhu J, Yu Z, Zhai F, Li H, Jin X. Li Y, et al. Am J Cancer Res. 2023 Oct 15;13(10):4832-4871. eCollection 2023. Am J Cancer Res. 2023. PMID: 37970337 Free PMC article. Review.
References
- Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D. W., Briand C., Grutter M. G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 2002;277:45162–45171. - PubMed
- Alnemri E. S., Livingston D. J., Nicholson D. W., Salvesen G., Thornberry N. A., Wong W. W., Yuan J. Human ICE/CED-3 protease nomenclature. Cell. 1996;87:171. - PubMed
- Boatright K. M., Renatus M., Scott F. L., Sperandio S., Shin H., Pedersen I., Ricci J.-E., Edris W. A., Sutherlin D. P., Green D. R., Salvesen G. S. A unified model for apical caspase activation. Mol. Cell. 2003;11:529–541. - PubMed
- Stennicke H. R., Salvesen G. S. Caspases: preparation and characterization. Methods. 1999;17:313–319. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous